Immunity to Hepatitis B Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

February 1, 2018

Study Completion Date

February 1, 2018

Conditions
Hepatitis BImmunization; Infection
Interventions
DRUG

Hepatitis B vaccine

1.0 ml (20 micrograms) suspension of hepatitis B surface antigen for intramuscular injection

Trial Locations (1)

V5Z 4H4

Vaccine Evaluation Center, Vancouver

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

collaborator

J. Craig Venter Institute

OTHER

collaborator

The Scripps Research Institute

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

Human Vaccines Project

OTHER

lead

University of British Columbia

OTHER